Bausch Health Companies (BHC) Restructuring Costs (2009 - 2026)
Bausch Health Companies (BHC) posted Restructuring Costs of $9.0 million for Q2 2026, down 30.77% sequentially from $13.0 million in Q1 2026, and down 70.97% YoY from $31.0 million in Q2 2025.
Bausch Health Companies (BHC) Restructuring Costs (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Restructuring Costs for 18 years, with the latest figure at $9.0 million in Q2 2026.
- Quarterly Restructuring Costs fell 70.97% year-over-year to $9.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $67.0 million (up 67.5% YoY) and the FY2025 annual result came in at $77.0 million, up 140.62% from the prior year.
- Restructuring Costs eased to $9.0 million in Q2 2026 per BHC's latest filing, from $13.0 million in the prior quarter.
- Over five years, Restructuring Costs peaked at $35.0 million in Q2 2022 and troughed at $1.0 million in Q3 2024.
- A 5-year average of $14.2 million and a median of $12.5 million in 2022 frame the typical range for Restructuring Costs.
- The sharpest annual moves came in 2024 and 2025: Restructuring Costs tumbled 92.86% in 2024, then soared 1600.0% in 2025.
- Over 5 years, Restructuring Costs stood at $5.0 million in 2022, then soared by 340.0% to $22.0 million in 2023, then slumped by 68.18% to $7.0 million in 2024, then jumped by 300.0% to $28.0 million in 2025, then plunged by 67.86% to $9.0 million in 2026.
- According to Business Quant data, Restructuring Costs over the past three periods registered $9.0 million, $13.0 million, and $28.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Bausch Health Companies | 2.58 Bn | 740.13 Mn | 2.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.00 Mn |
| Mar 31, 2026 | 13.00 Mn |
| Dec 31, 2025 | 28.00 Mn |
| Sep 30, 2025 | 17.00 Mn |
| Jun 30, 2025 | 31.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 7.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 12.00 Mn |
| Mar 31, 2024 | 12.00 Mn |
| Dec 31, 2023 | 22.00 Mn |
| Sep 30, 2023 | 14.00 Mn |
| Jun 30, 2023 | 16.00 Mn |
| Mar 31, 2023 | 10.00 Mn |
| Dec 31, 2022 | 5.00 Mn |
| Sep 30, 2022 | 10.00 Mn |
| Jun 30, 2022 | 35.00 Mn |
| Mar 31, 2022 | 13.00 Mn |
| Dec 31, 2021 | 21.00 Mn |
| Sep 30, 2021 | 8.00 Mn |